EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chlamydia muridarum mutant CM-pGP3S as a novel attenuated live rectal vaccine protects against genital tract infection

Jingyue Ma, Tianyuan Zhang, Qi Tian, Meng Xiao, Long Han, Quanzhong Liu, Guangming Zhong, Yuanjun Liu

Frontiers in Cellular and Infection Microbiology · 13.05.2025 · 15

DOI: 10.3389/fcimb.2025.1550455 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 13.05.2025. Verfasst von Jingyue Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatovenereology, Tianjin Medical University General Hospital/Tianjin Institute of Sexually Transmitted Disease, Tianjin, China. Hauptthemen laut MEDLINE: Chlamydia muridarum, Chlamydia Infections, Bacterial Vaccines, Reproductive Tract Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chlamydia trachomatis (CT) is a major sexually transmitted pathogen with severe complications. Using Chlamydia muridarum (CM) as a model, this study evaluates the attenuated mutant Chlamydia muridarum (CM-pGP3S) as a novel rectal vaccine to protect against genital tract infection and pathology.

Methods

Female C57BL/6 mice were rectally immunized with low (1×10 3 ), middle (1×10 5 ), or high (1×10 7 ) doses of CM-pGP3S. Mice were challenged intravaginally with wild-type Chlamydia muridarum 63 days post-immunization. Protection was assessed via genital Chlamydia shedding, hydrosalpinx incidence (gross/histopathology), serum IgG, fecal IgA, and T cell responses. Gut microbiota stability was analyzed using qPCR.

Results

CM-pGP3S immunization significantly reduced CM-WT genital shedding duration (3–7 days vs. 21 days in controls, p < 0.01) and hydrosalpinx incidence (0% vs. 80% in controls, p < 0.01). Elevated systemic and mucosal immunity were observed, including higher serum IgG (1:100–1:1600 dilutions, p < 0.05–0.01) and fecal IgA ( p < 0.05–0.01). CD4 + and CD8 + T cells exhibited increased IFN-γ ( p < 0.01), while CD8 + T cells showed elevated TNF-α and IL-2 ( p < 0.05). No colitis or significant gut microbiota disruption occurred post-immunization.

Discussion

Rectal CM-pGP3S vaccination induces robust transmucosal immunity, protecting against genital Chlamydia infection and pathology without gastrointestinal adverse effects. This highlights its potential as a safe and effective mucosal vaccine strategy to combat CT genital tract infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chlamydia muridarumChlamydia InfectionsBacterial VaccinesReproductive Tract InfectionsAnimalsFemaleVaccines, AttenuatedMice, Inbred C57BLMiceAntibodies, BacterialImmunoglobulin AImmunoglobulin GDisease Models, AnimalImmunity, MucosalBacterial SheddingGastrointestinal MicrobiomeFecesRectum

Stichwörter der Autor:innen

Chlamydia muridarumattenuated rectal vaccinegenital tract infectionmucosal immunitypGP3Srectal immunization

Substanzen

Bacterial VaccinesVaccines, AttenuatedAntibodies, BacterialImmunoglobulin AImmunoglobulin G

Autor:innen und Institutionen

  • Department of Dermatovenereology, Tianjin Medical University General Hospital/Tianjin Institute of Sexually Transmitted Disease, Tianjin, China.
  • Shanghai Institute of Virology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Obstetrics and Gynecology, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, China.
  • Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center at San Antonio, Texas, TX, United States.

Zitieren

APA

Ma, J., Zhang, T., Tian, Q., Xiao, M., Han, L., Liu, Q., Zhong, G., & Liu, Y. (2025). Chlamydia muridarum mutant CM-pGP3S as a novel attenuated live rectal vaccine protects against genital tract infection. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1550455

Vancouver

Ma J, Zhang T, Tian Q, Xiao M, Han L, Liu Q, et al. Chlamydia muridarum mutant CM-pGP3S as a novel attenuated live rectal vaccine protects against genital tract infection. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1550455

BibTeX
@article{Ma2025,
  author = {Ma, Jingyue and Zhang, Tianyuan and Tian, Qi and Xiao, Meng and Han, Long and Liu, Quanzhong and Zhong, Guangming and Liu, Yuanjun},
  title = {Chlamydia muridarum mutant CM-pGP3S as a novel attenuated live rectal vaccine protects against genital tract infection},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fcimb.2025.1550455}
}
Kostenlos starten →